COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia

  • Rahman A
  • Purdy A
  • Ender P
N/ACitations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Hydroxychloroquine has gained popularity as a potential preventative and treatment of COVID-19 pneumonia due to its in vitro activity against the virus. These three cases of COVID-19 pneumonia of varying severities occurred in the setting of chronic hydroxychloroquine use. These cases argue against the use of hydroxychloroquine as a preventative or therapeutic option for COVID-19 pneumonia.

Cite

CITATION STYLE

APA

Rahman, A. K., Purdy, A. G., & Ender, P. T. (2020). COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia. Case Reports in Infectious Diseases, 2020, 1–4. https://doi.org/10.1155/2020/8822753

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free